Functionalized exendin-4 derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9670261
SERIAL NO

14135801

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI54 RUE LA BOETIE PARIS 75008

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Evers, Andreas Frankfurt am Main, DE 46 435
Haack, Torsten Frankfurt am Main, DE 42 455
Henkel, Bernd Frankfurt am Main, DE 24 427
Lorenz, Katrin Frankfurt am Main, DE 31 260
Lorenz, Martin Frankfurt am Main, DE 24 217
Stengelin, Siegfried Frankfurt am Main, DE 84 1572
Wagner, Michael Frankfurt am Main, DE 194 2499

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00